Erin Doty

Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine

David W. Dodick, Erin Doty, Sheena K. Aurora et al. · Cephalalgia · 2020 · 101 citations

Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials

Robert E. Shapiro, Helen Hochstetler, Ellen B. Dennehy et al. · The Journal of Headache and Pain · 2019 · 85 citations · Full text

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN

John H. Krege, Paul Rizzoli, Emily Liffick et al. · Cephalalgia · 2019 · 71 citations · Full text

Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study

Messoud Ashina, Uwe Reuter, Timothy R. Smith et al. · Cephalalgia · 2021 · 68 citations · Full text

Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls

Eric Pearlman, Darren Wilbraham, Ellen B. Dennehy et al. · Human Psychopharmacology Clinical and Experimental · 2020 · 61 citations · Full text